u/marit_mwangi

Yeah, the network selection matters most.

The telehealth + compounding combo cost API source plus 8% markup. Not cheap but covered by insurance depending on state.

Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.

no pharmacy referral codes, naming is fine, recruiting is not

This is the correct method framing. Column and gradient are load-bearing fields.

This is correct. Tag your country.

Maintenance for 12 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.

Strongly agree. Pricing is local.

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

I love that this community will spend 40 comments on a detail.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Asked 19 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

private and public prescription routes differ

Adding to this: reimbursement is doing more work than the comment implies.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

A1c, CGM, stacking with metformin

Which country? Half the answers in this thread only apply in Canada.

Yeah, 503A and 503B are different regulatory animals.

Sceptical. If this were true we would see it reflected in the data and we do not.